Astronaut loading animation Circular loading bar

Try : Insurtech, Application Development

AgriTech(1)

Augmented Reality(20)

Clean Tech(5)

Customer Journey(12)

Design(35)

Solar Industry(6)

User Experience(55)

Edtech(10)

Events(34)

HR Tech(2)

Interviews(10)

Life@mantra(11)

Logistics(5)

Strategy(17)

Testing(9)

Android(47)

Backend(30)

Dev Ops(7)

Enterprise Solution(27)

Technology Modernization(2)

Frontend(28)

iOS(43)

Javascript(15)

AI in Insurance(35)

Insurtech(63)

Product Innovation(49)

Solutions(19)

E-health(10)

HealthTech(22)

mHealth(5)

Telehealth Care(4)

Telemedicine(5)

Artificial Intelligence(132)

Bitcoin(8)

Blockchain(19)

Cognitive Computing(7)

Computer Vision(8)

Data Science(17)

FinTech(50)

Banking(7)

Intelligent Automation(26)

Machine Learning(47)

Natural Language Processing(14)

expand Menu Filters

Google IO 2016 Day 2 – Review

Google IO 2016 continued with Day 2 announcements and news about Google Daydream VR. As expected plenty of discussion were on VR, Google Play improvements and Google Cloud and Android Wear updates.

The second day of the show was a bit calmer by design in order to let developers get down into the details of everything that was announced on day 1, but there’s still plenty of newsworthy information out there from day 2.

The big headlines of the day were fresh details on Daydream VR, the final announcement that the Play Store is coming to Chrome OS and as expected Android Instant App stayed star of the 2nd day as well.

[section_tc][column_tc span=’12’][youtube_tc id=’https://www.youtube.com/watch?v=862r3XS2YB0′][/youtube_tc][/column_tc][/section_tc]

The day 2nd at Google I/O 2016 continued with detailed explanations of announcements made on Day 1, but DayDream and Instant App stayed stars from Day 1:

  1. DayDream VR – Day 2
    Though we got a pretty solid rundown of Daydream VR at the Day 1 keynote, a handful of sessions on Day 2 gave us all of the deep details on Google’s new virtual reality push in Android N. We now know that the Nexus 6P is the first device set up to develop Daydream compatible apps, and Google has also launched a system for using another phone as a controller in lieu of yet-to-be-released Daydream controllers.Google also confirmed that it plans to release its own takes on the Daydream headset and controller designs, though the focus is still on third-party manufacturers making their own. On the content side, Google gave a sneak peek of the new virtual reality launcher in Android N, as well as new content offerings from YouTube, Google Play Movies and more. For content creation, Google announced partnerships and integrations with movie makers, developers and game engine creators.google-daydream-vr(1)
  2. Android Instant App- Day 2
    The “Android Instant App” continued to remain the star of 2nd day as well. With the buzz over Google’s new “Android Instant Apps” initiative that will enable Android devices to pull down specific parts of apps without downloading and installing a full app, it’s reasonable to expect the feature will make its way to Chrome OS. Speaking at a Q&A session after the announcement, the Chrome OS team from Google explained that anything designed to work on Android “should just work” on Chrome OS — yes, including Android Instant Apps.Google-Android-Instant-Apps-03

Google also provided little details on Google Home, Google Assistant and Android N, but asked people to wait for the year fall and its release.

The two new big announcement of the day 2 were:

  1. Chrome OS
    After being heavily rumored, Google finally dropped the news on us — Google Play is coming to Chrome OS. Later this year, Chromebooks, Chromeboxes and Chromebases will be able to launch the Google Play Store and download millions of Android apps. Those apps will run as first-class citizens on the system, right next to any Chrome apps you may have.

Unlike the ARC Welder that preceded it, this new implementation opens up a world of possibilities for consumers to get great apps on their Chromebooks.

Play-Store-app-on-Chrome-browsewr-624x351(1)

  1. Google Play Awards
    Google I/O
    is all about developers, and part of that story is giving praise to the developers that make the fantastic apps that Google itself notices as being exceptionally great. Google took time after the show on Day 2 to highlight these apps, and while there are big names included that you’ve heard of, there are plenty that you haven’t seen that were worth highlighting and checking out.

Manufacturers are free to choose between Chrome OS and Android

With the lines blurring between the experience of using Android and using Chrome OS, Google’s Hiroshi Lockheimer also said that there isn’t any specific screen size or device type where Google will tell a manufacturer whether it should choose Android or Chrome OS as their system of choice.

Chrome OS is still obviously tailored toward larger devices with a keyboard and mouse, while Android works best on smaller touch-only form factors, but if a manufacturer wants to cross the typical lines now that Chrome OS supports Android apps they’re free to do so. There will continue to be mainstream Chromebooks out there that have convertible form factors and resemble something more like a tablet, and on the other side of things companies can still choose to make Android-powered laptops if they wish.

Google also announced later yesterday that it was in the process of developing a faster chip – known as Tensor Processing Unit – to speed up transactions in artificial intelligence. Not much is known about the chip, however, and the company promised to detail later this year.

The 3rd day expectations are also high. For updates of 3rd day stay with Mantra Labs.

If any queries approach us on hello@mantralabsglobal.com

Cancel

Knowledge thats worth delivered in your inbox

Embracing the Digital Frontier: Transforming the Patient Journey in Pharma

In the realm of pharmaceuticals, the digital revolution is not just a buzzword; it’s a seismic shift reshaping the landscape of patient care. From discovery to delivery, digital technologies are revolutionizing every facet of the pharmaceutical industry. One of the most profound impacts is evident in the patient journey. Today’s Patients are more informed, engaged, and empowered than ever, thanks to the proliferation of digital tools and platforms. In this comprehensive exploration, we will delve into the multifaceted ways digital is redefining the patient journey in pharmaceuticals.

According to a report by Accenture on the rise of digital health, these are the key challenges to overcome:

  • 99% of respondents indicated that the development and commercialization of Digital Health solutions has accelerated in the past two years. As part of this, companies require various new and strengthened capabilities to execute their visions. 
  • Patients and health professionals need to trust that the data collected is accurate, safe, and secure for them to feel comfortable using it. 
  • Fragmented data or lack of access to data has been a barrier to development. An overarching guideline on data privacy is needed.

Leveraging Digital Solutions for Accessible Drug Delivery

In the pharmaceutical industry, the journey of medication from production facilities to patients’ hands is evolving with the integration of digital solutions. These technologies not only streamline logistics but also ensure that medications reach even the most remote and underserved areas. Let’s delve into how digital innovations are transforming drug delivery and backend channels in the pharmaceutical industry.

Digital Backend Channels and Supply Chain Management:

Pharmaceutical firms leverage digital tech for efficient backend operations. Software like SAP Integrated Business Planning and Oracle SCM Cloud enable real-time tracking, inventory management, and demand forecasting. With AI and analytics, companies adapt to market changes swiftly, ensuring timely medication delivery and optimized supply chain logistics.

Innovative Digital Drug Delivery Technologies:

  1. Controlled Monitoring Systems: Digital temperature monitoring systems provide digital temperature monitoring solutions using IoT sensors and cloud platforms, safeguarding temperature-sensitive medications during transit, ensuring compliance with regulatory standards, and minimizing product spoilage risk.
  1. Last-Mile Delivery Platforms: Zipline and Nimblr.ai, along with LogiNext, employ digital last-mile delivery solutions, using drones and AI-powered logistics to transport vital medical supplies efficiently to remote regions, improving accessibility for underserved communities.
  1. Telemedicine Integration with Prescription: Integrated telemedicine and prescription platforms, like Connect2Clinic, are rapidly growing in response to COVID-19. With telehealth claims at 38 times pre-pandemic levels, the industry is projected to hit $82 billion by 2028, with a 16.5% annual growth rate. Mantra Labs partnered with Connect2Clinic, enabling seamless coordination between healthcare providers, pharmacies, and patients. This facilitates virtual consultations and electronic prescribing, benefiting remote patients with medical advice and prescriptions without in-person visits. These platforms enhance healthcare access, medication adherence, and patient engagement through personalized care plans and reminders.
  1. Community Health Worker Apps: CommCare and mHealth empower community health workers with digital tools for medication distribution, education, and patient monitoring. Customizable modules enable tracking inventories, health assessments, and targeted interventions, extending pharmaceutical reach to remote communities, and ensuring essential medications reach those in need.

Through the strategic deployment of digital solutions in drug delivery and backend channels, pharmaceutical companies are overcoming barriers to access and revolutionizing healthcare delivery worldwide. By embracing innovation and collaboration, they are not only improving patient outcomes but also advancing toward a more equitable and inclusive healthcare system.

Personalized Medicine:

Wearable devices and mobile apps enable personalized medicine by collecting real-time health data and tailoring treatment plans to individual needs. For example, fitness trackers monitor activity and vital signs, customizing exercise and medication. Personalized medicine optimizes efficacy, minimizes adverse effects, and enhances patient satisfaction by leveraging patient-specific data.

Enhanced Patient Engagement:

Pharmaceutical firms utilize digital platforms for patient engagement, fostering support and education during treatment. Through social media, mobile apps, and online communities, patients connect, access resources, and receive professional support. Two-way communication enhances collaboration and decision-making, boosting treatment adherence, health outcomes, and consumer loyalty. Click here to know more.

Data-Driven Insights:

The abundance of healthcare data offers pharma companies unique opportunities to understand patient behavior and treatment patterns. By leveraging big data analytics and artificial intelligence, they extract actionable insights from various sources like electronic health records and clinical trials. These insights inform targeted marketing, product development, and patient support programs. However, ensuring data privacy and security is crucial, requiring robust regulatory frameworks and transparent practices in the digital era.

Challenges and Considerations:

Maximizing the benefits of digital technologies requires addressing challenges like patient data privacy and equitable access to healthcare tech. Stringent safeguards are needed to protect confidentiality and trust, alongside efforts to bridge the digital divide. Regulatory frameworks must evolve to balance innovation with patient safety and security amidst rapid advancements in digital health.

Key Considerations for Pharma Companies in Embracing Digital Innovation:

  • Prioritize patient-centricity in digital initiatives, focusing on improving patient outcomes and experiences.
  • Invest in robust data privacy and security measures to build and maintain patient trust.
  • Foster collaboration and partnerships with technology companies and healthcare providers to drive innovation and scalability.
  • Leverage analytics and AI to derive actionable insights from healthcare data and inform decision-making processes.
  • Continuously monitor and adapt to regulatory requirements and industry standards to ensure compliance and mitigate risks.

Conclusion:

The digital revolution is not just a paradigm shift but a catalyst for transformation across the pharmaceutical industry. By embracing digital technologies, pharma companies can unlock new opportunities to enhance the patient journey, improve treatment outcomes, and drive sustainable growth. However, realizing the full potential of digital health requires collaboration, innovation, and a steadfast commitment to addressing the challenges and considerations inherent in this transformative journey. As we navigate the digital frontier, the future of patient care promises to be more connected, personalized, and empowering than ever before.

Cancel

Knowledge thats worth delivered in your inbox

Loading More Posts ...
Go Top
ml floating chatbot